← Back to home

One-Time CRISPR Treatment Holds Down Monkey Triglycerides for Three Years

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Researchers at Verve Therapeutics, an Eli Lilly subsidiary, report in the journal Nature that switching off a liver gene…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

4 confirmed facts, 2 open questions and 2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home
One-Time CRISPR Treatment Holds Down Monkey Triglycerides for Three Years — NewsPlain